Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review - 01/06/22

Doi : 10.1016/j.annder.2021.07.007

M. Chastagner ^a,^{^{1
M. Chastagner and J. Shourik are co-first authors.}}, J. Shourik ^b,^{^{1
M. Chastagner and J. Shourik are co-first authors.}}, M. Jachiet ^c, M. Battistella ^d, G. Lefevre ^e,^f, J.-B. Gibier ^g, H. Aubert ^h, M. Musquer ⁱ, V. Descamps ^j, L. Deschamps ^k, O. Chosidow ^l, N. Ortonne ^m, M. Groh ^e,ⁿ, M. Bernier ^o, D. Jullien ^a, F. Chasset ^b, D. Staumont-Salle ^p, J.-D. Bouaziz ^c, J. Kanitakis ^a,^{^{2
J. Kanitakis and A.P. Villani are co-last authors.}}, A.P. Villani ^a,^{^{2
J. Kanitakis and A.P. Villani are co-last authors.},}^⁎
^a Department of Dermatology, CHU Lyon, Université Claude Bernard Lyon I, 69000 Lyon, France
^b Sorbonne université, Faculté de médecine, Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, 75020 Paris, France
^c Department of Dermatology, Hôpital Saint-Louis, AP-HP Université de Paris, 75010 Paris, France
^d Pathology Department, Hôpital Saint-Louis, AP-HP, Université de Paris, Inserm U976, 75010 Paris, France
^e CEREO (National reference center for Hypereosinophilic Syndromes), 75010 Paris, France
^f Department of Internal Medicine, CHU Lille, 59000 Lille, France
^g Pathology Department, CHU Lille, 59000 Lille, France
^h Dermatology Department, CHU Nantes, 44000 Nantes, France
ⁱ Pathology Department, CHU, 44000 Nantes, France
^j Dermatology Department, Hôpital Bichat, 75018 Paris, France
^k Pathology Department, Hôpital Bichat, 75018 Paris, France
^l Faculté de Santé de Créteil et Service de Dermatologie, APHP, Hôpital Henri-Mondor, Université Paris-Est, Créteil, France and Research Group Dynamic, EA7380, Faculté de Santé de Créteil, Ecole Nationale Vétérinaire d’Alfort, USC ANSES, Université Paris-Est Créteil, 94010 Créteil, France
^m Pathology Department, Hôpital Mondor, CHU Créteil, 94010 Créteil, France
ⁿ Department of Internal Medicine, Hôpital Foch, 92150 Suresnes, France
^o Pathology Department, Hôpital Foch, 92150 Suresnes, France
^p Department of Dermatology, CHU Lille, Inserm U1286 INFINITE (Institute for Translational Research in Inflammation), University Lille, 59000 Lille, France

^⁎Corresponding author at: Hôpital Edouard Herriot–Service de Dermatologie–Pavillon R, 5, place d’Arsonval, 69003 Lyon, France.Hôpital Edouard Herriot–Service de Dermatologie–Pavillon R5, place d’ArsonvalLyon69003France

Abstract

Background

Eosinophilic annular erythema (EAE) is a rare eosinophil-related skin disease which typically manifests with annular erythematous plaques and severe pruritus. Besides the diagnosis, the treatment of EAE is challenging since relevant published data are sparse.

Methods

The aim of this study was to assess the underlying diseases, treatments and outcomes of patients with EAE. To this end, we conducted a retrospective multicenter study and a systematic review of the MEDLINE database.

Results

We included 18 patients with EAE followed in 8 centers. The MEDLINE database search yielded 37 relevant publications reporting 55 cases of EAE with 106 treatment sequences. The most common and efficient treatments included topical or systemic corticosteroids, hydroxychloroquine and dapsone. In refractory patients, a combination of systemic corticosteroids with hydroxychloroquine was associated with 88% of complete clinical response.

Discussion

To improve the management of EAE patients, we discuss the following treatment strategy: in topical steroid-resistant patients, hydroxychloroquine can be given as first-line systemic treatment. Dapsone, hydroxychloroquine or systemic corticosteroids are second-line options to consider. Last, monoclonal antibodies or JAK inhibitors targeting type 2 inflammation could represent promising last-resort options in refractory patients.

Le texte complet de cet article est disponible en PDF.

Keywords : Eosinophilic annular erythema, Eosinophil, Wells syndrome, Eosinophilic cellulitis, Treatment

Plan

Introduction

Patients and methods

Patients from the retrospective multicenter study

Literature review

Results

Multicenter retrospective study

Review of the MEDLINE database

Discussion

Funding

Disclosure of interest

Export

Vol 149 - N° 2

P. 123-127 - juin 2022 Retour au numéro

Article précédent

Erysipelas of the leg: A cross-sectional study of risk factors for recurrence
F. Hali, S. Belanouane, K. Zarouali Ouariti, M. Sodqi, S. Chiheb

| Article suivant

Variable expressivity in Buschke-Ollendorff syndrome
D. Salik, G. Dupire, U. Sass, C. Dangoisse, D. Franck, A. Labadens, M. Marangoni, C. Vilain, G. Smits

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review - 01/06/22

Abstract

Background

Methods

Results

Discussion

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL